Category

Parkinson’s disease

Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.

By | ALL, Alzheimer's Disease, Huntington's disease, Hutchinson-Gilford progeria syndrome, Neurodegenerative Diseases, Parkinson's disease, Rapamycin | No Comments

Author: JW Larrick, AR Mendelsohn. Rejuvenation Res. 2011 Aug;14(4):437-41. Mammalian target of rapamycin (mTOR), a serine/threonine kinase and component of the mTORC1 signaling complex, acts as an energy, nutrient, growth factor, stress, and redox sensor to…

Read More